Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 May;90(5):609-11.
doi: 10.1136/bjo.2005.083428.

The in vitro activity of selected defensins against an isolate of Pseudomonas in the presence of human tears

Affiliations

The in vitro activity of selected defensins against an isolate of Pseudomonas in the presence of human tears

A M McDermott et al. Br J Ophthalmol. 2006 May.

Abstract

Background/aims: Pseudomonas aeruginosa is a major cause of severe bacterial keratitis and remains a difficult clinical entity to treat successfully with the current arsenal of antimicrobial agents. Defensins are small cationic peptides with broad in vitro antimicrobial activity and are potential ocular therapeutic agents. The authors characterised the in vitro activity of defensins NP-1 and NP-3a against P aeruginosa in the presence of human tears.

Methods: A clinical Pseudomonas isolate was grown to mid-log phase, and 1 x 10(6 )colony forming units were exposed to the peptides (200 microg/ml) for up to 2 hours in the presence of varying concentrations (10-70%) of human tears.

Results: For both peptides in the presence of 10% tears, >3 log units of killing was achieved within 30 minutes. In 70% tears, NP-1 produced >1 log unit of killing at 2 hours, indicating that, although reduced, its activity remained significant. In 20% tears, NP-3a demonstrated 2 log units of killing at 2 hours; however, the antimicrobial activity of this defensin was completely inhibited in the presence of 70% tears.

Conclusion: These in vitro data suggest that while the microbicidal activity of some defensins may be diminished at the ocular surface in vivo, significant activity is still possible with certain peptides.

PubMed Disclaimer

References

    1. Schafer F, Bruttin O, Zografos L.et al Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol 200185842–847. - PMC - PubMed
    1. Bourcier T, Thomas F, Borderie V.et al Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol 200387834–838. - PMC - PubMed
    1. Mela E K, Giannelou I P, Koliopoulous J X.et al Ulcerative keratitis in contact lens wearers. Eye Contact Lens 200329207–209. - PubMed
    1. Hoban D J, Biedenbach D J, Mutnick A H.et al Pathogen occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000). Diagn Microbiol Infect Dis 200345279–285. - PubMed
    1. Mutnick A H, Rhomberg P R, Sader H S.et al Antimicrobial usage and resistance trend relationships from the MYSTIC Program in North America (1999–2001).J Antimicrob Chemother 200453290–296. - PubMed

Publication types